Certara’s Phoenix Platform – The world’s most trusted platform for PK/PD analysis and modeling Video Certara Phoenix 平台 — 全球最值得信赖的药代动力学/药效学(PK/PD)分析与建模平台 Today's drug candidates are more complex than ever. But with development decisions on the line,…Certara2025 年 2 月 12 日
Simulations to Inform Dose Selection for a Phase 2b Trial Investigating TOUR006, a Fully Human Anti-IL6 Antibody, for Treatment of Thyroid Eye Disease Poster 利用模拟结果为探索全人源抗 IL-6 抗体 TOUR006 治疗甲状腺眼病的 IIb 期试验确定剂量 Danielle Pillsbury2025 年 2 月 7 日
Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses Publication 在暴露-反应分析中使用时间平均暴露指标对二元终点的影响 This Frontiers in Pharmacology article investigates how using different time-averaged exposure metrics, specifically the time-averaged…Danielle Pillsbury2025 年 1 月 21 日
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region Publication 利用模型引导的药物开发(MIDD)方法以优化临床试验设计与监管决策面向中东和北非地区(MENA)的入门指南 The integration of MID3 offers a transformative opportunity for the MENA region to advance pharmaceutical…Danielle Pillsbury2025 年 1 月 14 日
Solving Drug Development Challenges with Model-Based Meta-Analysis (MBMA) On-Demand Webinar 利用基于模型的荟萃分析 (MBMA) 解决药物开发难题 In this on-demand webinar, "MBMA: Optimizing Drug Development with Aggregate Clinical Trial Data and Predictive…Danielle Pillsbury2025 年 1 月 9 日
INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease Publication INTERCEPT-AD:一项针对阿尔茨海默病所致轻度认知障碍或轻度痴呆患者的静脉注射 Sabirnetug 的 I 期研究 The Phase 1 INTERCEPT-AD study evaluated sabirnetug (ACU193), a monoclonal antibody targeting amyloid-beta oligomers (AβOs),…Danielle Pillsbury2025 年 1 月 8 日
From Research to Real-World Impact: A Model Informed Drug Development (MIDD) Framework to Support Understudied Populations On-Demand Webinar 从研究到对真实世界的影响:模型引导的药物开发(MIDD)框架,以支持对研究不足人群的支持 SVP, Client and Regulatory Strategy, Certara Dr. Karen Rowland Yeo is Senior Vice-President, Client &…Danielle Pillsbury2025 年 1 月 3 日
Population Pharmacokinetics (PopPK) of Revumenib in Patients with Relapsed/Refractory Acute Leukemias Poster Revumenib 在复发性/难治性急性白血病患者中的群体药代动力学 (PopPK) Danielle Pillsbury2024 年 12 月 12 日
Advancing pharmacometrics in Africa – Transition from capacity development toward job creation Publication 推动非洲定量药理学的发展 — 从能力建设向创造就业过渡 This CPT article showcases, the Applied Pharmacometrics Training (APT) program, launched in 2021 by Pharmacometrics…Danielle Pillsbury2024 年 12 月 9 日
PK/PD Data Analysis, Concepts and Applications eBook eBook 《药代动力学/药效学(PK/PD)数据分析:概念与应用》电子书 加速您的历程:通过 PK 科学家标准手册学习与成长Simona Colucci2024 年 11 月 25 日